can glp-1 cause cancer Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials Does GLP-1 Increase Risk of
Description
Overall, 35% heard about compounded GLP-1 concerns
Noabrupt discontinuation can trigger rebound appetite and metabolic disruption
They also point out that U.S
Abstract Glucagon-like-peptide-1 (GLP-1) and its long acting analogs comprise a novel class of type 2 diabetes (T2D) treatment
Treatment recommendations are individualized and based on safety, appropriateness, and clinical judgment
Compounded formulations have not been individually evaluated by the FDA for safety, effectiveness, or quality
